Literature DB >> 20977192

Organometallic osmium arene complexes with potent cancer cell cytotoxicity.

Ying Fu1, Abraha Habtemariam, Ana M Pizarro, Sabine H van Rijt, David J Healey, Patricia A Cooper, Steven D Shnyder, Guy J Clarkson, Peter J Sadler.   

Abstract

Iodido osmium(II) complexes [Os(η(6)-arene)(XY)I](+) (XY = p-hydroxy or p-dimethylaminophenylazopyridine, arene = p-cymene or biphenyl) are potently cytotoxic at nanomolar concentrations toward a panel of human cancer cell lines; e.g., IC(50) = 140 nM for [Os(η(6)-bip)(azpy-NMe(2))I](+) toward A2780 ovarian cancer cells. They exhibit low toxicity and negligible deleterious effects in a colon cancer xenograft model, giving rise to the possibility of a broad therapeutic window. The most active complexes are stable and inert toward aquation. Their cytotoxic activity appears to involve redox mechanisms.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20977192     DOI: 10.1021/jm100560f

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  19 in total

1.  Synthesis, structure and anticancer properties of new biotin- and morpholine-functionalized ruthenium and osmium half-sandwich complexes.

Authors:  Mickaël Marloye; Haider Inam; Connor J Moore; Vinciane Debaille; Justin R Pritchard; Michel Gelbcke; Franck Meyer; François Dufrasne; Gilles Berger
Journal:  J Biol Inorg Chem       Date:  2021-06-26       Impact factor: 3.358

2.  Potent organo-osmium compound shifts metabolism in epithelial ovarian cancer cells.

Authors:  Jessica M Hearn; Isolda Romero-Canelón; Alison F Munro; Ying Fu; Ana M Pizarro; Mathew J Garnett; Ultan McDermott; Neil O Carragher; Peter J Sadler
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-10       Impact factor: 11.205

3.  A novel Osmium-based compound targets the mitochondria and triggers ROS-dependent apoptosis in colon carcinoma.

Authors:  A Maillet; S Yadav; Y L Loo; K Sachaphibulkij; S Pervaiz
Journal:  Cell Death Dis       Date:  2013-06-06       Impact factor: 8.469

4.  Metal-Arene Complexes with Indolo[3,2-c]-quinolines: Effects of Ruthenium vs Osmium and Modifications of the Lactam Unit on Intermolecular Interactions, Anticancer Activity, Cell Cycle, and Cellular Accumulation.

Authors:  Lukas K Filak; Simone Göschl; Petra Heffeter; Katia Ghannadzadeh Samper; Alexander E Egger; Michael A Jakupec; Bernhard K Keppler; Walter Berger; Vladimir B Arion
Journal:  Organometallics       Date:  2013-01-17       Impact factor: 3.876

5.  Mirror-image organometallic osmium arene iminopyridine halido complexes exhibit similar potent anticancer activity.

Authors:  Ying Fu; Rina Soni; María J Romero; Ana M Pizarro; Luca Salassa; Guy J Clarkson; Jessica M Hearn; Abraha Habtemariam; Martin Wills; Peter J Sadler
Journal:  Chemistry       Date:  2013-09-23       Impact factor: 5.236

6.  Enhancement of Selectivity of an Organometallic Anticancer Agent by Redox Modulation.

Authors:  Isolda Romero-Canelón; Magdalena Mos; Peter J Sadler
Journal:  J Med Chem       Date:  2015-09-23       Impact factor: 7.446

7.  Synchrotron X-Ray Fluorescence Nanoprobe Reveals Target Sites for Organo-Osmium Complex in Human Ovarian Cancer Cells.

Authors:  Carlos Sanchez-Cano; Isolda Romero-Canelón; Yang Yang; Ian J Hands-Portman; Sylvain Bohic; Peter Cloetens; Peter J Sadler
Journal:  Chemistry       Date:  2017-01-26       Impact factor: 5.236

Review 8.  Metallodrugs are unique: opportunities and challenges of discovery and development.

Authors:  Elizabeth J Anthony; Elizabeth M Bolitho; Hannah E Bridgewater; Oliver W L Carter; Jane M Donnelly; Cinzia Imberti; Edward C Lant; Frederik Lermyte; Russell J Needham; Marta Palau; Peter J Sadler; Huayun Shi; Fang-Xin Wang; Wen-Ying Zhang; Zijin Zhang
Journal:  Chem Sci       Date:  2020-11-12       Impact factor: 9.825

9.  Osmium(ii) tethered half-sandwich complexes: pH-dependent aqueous speciation and transfer hydrogenation in cells.

Authors:  Sonia Infante-Tadeo; Vanessa Rodríguez-Fanjul; Abraha Habtemariam; Ana M Pizarro
Journal:  Chem Sci       Date:  2021-06-10       Impact factor: 9.825

10.  Organometallic Iridium(III) anticancer complexes with new mechanisms of action: NCI-60 screening, mitochondrial targeting, and apoptosis.

Authors:  Jessica M Hearn; Isolda Romero-Canelón; Bushra Qamar; Zhe Liu; Ian Hands-Portman; Peter J Sadler
Journal:  ACS Chem Biol       Date:  2013-04-25       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.